On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...